Coya Therapeutics, Inc. ( COYA) - Key Metrics
COYA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.28 | -$582.95 | -$582.91 |
| 2026Q1 | $0.01 | -$0.32 | -$0.27 | -$0.27 |
| 2025Q4 | $0.24 | -$0.34 | -$0.06 | -$0.06 |
| 2025Q3 | $0.21 | -$0.13 | -$0.07 | -$0.07 |
| 2025Q2 | $0.01 | -$0.36 | -$0.35 | -$0.35 |
COYA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -5.22 |
| 2026Q1 | 0% | -3.08 |
| 2025Q4 | 0% | -4.26 |
| 2025Q3 | 0% | -10.96 |
| 2025Q2 | 0% | -3.99 |
COYA
Price: $4.38
52 week price:
Earnings Per Share: -1.09 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Market Capitalization: 107.7 million